Results 1 to 10 of about 3,933 (187)
Anti-Laminin 332-Type Mucous Membrane Pemphigoid [PDF]
Biomolecules, 2022 Anti-laminin (LM) 332-type mucous membrane pemphigoid (MMP) is a rare autoimmune bullous disease and was originally discovered as anti-epiligrin cicatricial pemphigoid.
Luhuai Shi, Xiaoguang Li, Hua Qian
doaj +5 more sources
Mucous Membrane Pemphigoid in a Nonagenarian: A Case Report [PDF]
Annals of Geriatric Medicine and Research, 2023 Mucous membrane pemphigoid is a rare autoimmune blistering disease characterized by post-bullous erosion of mucous membranes. Herein, we present a case of a nonagenarian man who was referred to our department of dermatology presenting with painful ...
Océane Babin de Lignac +5 more
doaj +3 more sources
Mucous membrane pemphigoid [PDF]
Autoimmunity Reviews, 2022 Mucous membrane pemphigoid (MMP) is a clinically and immunopathologically heterogenous disease with an incidence of about 2/million inhabitants/year in central Europe. Pemphigoid diseases are characterized by autoantibodies against structural proteins of the epidermis and/or surface-close epithelia.
Sabrina Patzelt +2 more
exaly +5 more sources
Evaluation of the Diagnostic Value of Oesophageal Biopsies for Direct Immunofluorescence Microscopy in Mucous Membrane Pemphigoid [PDF]
Acta Dermato-Venereologica, 2023 Mucous membrane pemphigoid is an autoimmune blistering disorder characterized by predominant involvement of surface-close epithelia and linear depositions of immunoreactants at the dermal-epithelial junction on direct immunofluorescence microscopy.
Kaan Yilmaz +6 more
doaj +3 more sources
The Diagnosis and Blistering Mechanisms of Mucous Membrane Pemphigoid [PDF]
Frontiers in Immunology, 2019 Mucous membrane pemphigoid (MMP) is a mucous membrane-dominated autoimmune subepithelial blistering disease that is caused by autoantibodies against various autoantigens in basement membrane zone (BMZ) proteins, including collagen XVII (COL17 ...
Mayumi Kamaguchi +2 more
doaj +4 more sources
Mucous Membrane Pemphigoid [PDF]
Dental Clinics of North America, 2013 Mucous membrane pemphigoid (MMP) is chronic and frequently associated with exacerbations and remissions of clinical signs and symptoms. Clinicians should use pathologic and immunonologic techniques to help diagnose patients. Multidisciplinary collaboration is often necessary for the diagnosis and proper treatment of MMP.
Victoria P Werth, Thomas P Sollecito
exaly +4 more sources
Oral Mucous Membrane Pemphigoid. [PDF]
J Microsc Ultrastruct, 2022 Abstract Pemphigoid is a group of rare autoimmune diseases affecting the skin and the mucous membrane in which the autoantibodies are directed against the basement membrane zone target antigens causing subepithelial blistering. Oral health professionals are usually the first to identify as more than 90% of cases show oral lesions initially. A
Babu C +3 more
europepmc +3 more sources
Gut Dysbiosis in Ocular Mucous Membrane Pemphigoid [PDF]
Frontiers in Cellular and Infection Microbiology, 2022 Mucous Membrane Pemphigoid is an orphan multi-system autoimmune scarring disease involving mucosal sites, including the ocular surface (OcMMP) and gut. Loss of tolerance to epithelial basement membrane proteins and generation of autoreactive T cell and ...
Liying Low +15 more
doaj +2 more sources
Successful Treatment of Mucous Membrane Pemphigoid with Dupilumab: A Case Report [PDF]
Acta Dermato-Venereologicais missing (Short communication)
Zhiyi Wang +5 more
doaj +2 more sources
Tofacitinib for refractory ocular mucous membrane pemphigoid [PDF]
American Journal of Ophthalmology Case Reports, 2021 Purpose: To report the successful use of tofacitinib in the treatment of refractory ocular mucous membrane pemphigoid (MMP). Observations: Two patients with ocular MMP presented with refractory disease after failure of multiple therapies.
Hayley James +5 more
doaj +2 more sources